子宮頸發育不良市場（依診斷類型、最終使用者和地區）

Cervical Dysplasia Market, By Diagnosis Type, By End User, By Geography

出版日期: 2025年03月03日 | 出版商:

Coherent Market Insights | 英文 145 Pages | 商品交期: 2-3個工作天內

價格

簡介目錄

2025 年全球子宮頸發育不良市場規模估計為 8.222 億美元，預計到 2032 年將達到 13.64 億美元，2025 年至 2032 年的年複合成長率（CAGR）為 7.5%。

報告範圍		報告詳細資訊
基準年	2024	2025年的市場規模	8.222億美元
效能數據	2020-2024	預測期	2025-2032
預測期間：2025年至2032年的複合年成長率	7.50%	2032年價值預測	13.64億美元

數字。 2025年子宮頸發育不良市場佔有率（按地區分類）

子宮頸發育不良是子宮頸（子宮開口）內壁細胞的癌前病變。這些變化是透過對骨盆檢查期間從子宮頸採集的細胞樣本進行顯微分析來檢測的。鱗狀上皮內病變是一個病理學術語，指從子宮頸採集的細胞抹片樣本中看到的子宮頸發育不良。子宮頸發育不良是由人類乳突病毒 (HPV) 感染引起的。 HPV 是一種非常常見的感染疾病，透過性接觸傳染。大多數新的 HPV 感染發生在年輕女性（15-25 歲）。大多數 HPV感染疾病不會引起症狀並且會自行消失。

市場動態

預計主要市場參與企業不斷增加的有機策略將在預測期內推動市場成長。例如，2021年3月1日，專注於推出精準設計的去氧核糖核酸（DNA）藥物，用於治療和預防感染疾病、癌症和HPV相關疾病的生物技術公司Inovio宣布，其REVEAL 1測試的所有可評估受試者均達到了主要和次要終點。該測試是兩項正在進行的關鍵、隨機、雙盲、多中心、安慰劑對照的 3 期研究之一，使用我們專有的 Selectra 5 PSP 設備評估 VGX-3100 在 HPV-16/18 相關子宮頸高級別鱗狀上皮內病變 (HSIL) 中的安全性、耐受性和有效性。

Report Coverage	Report Details
Base Year:	2024	Market Size in 2025:	USD 822.2 Mn
Historical Data for:	2020 To 2024	Forecast Period:	2025 To 2032
Forecast Period 2025 to 2032 CAGR:	7.50%	2032 Value Projection:	USD 1,364. Mn

Cervical dysplasia is precancerous changes of the cells that make up the lining of the cervix, the opening to the womb (uterus). These changes are detected by microscopic analysis of cell samples which are taken from the cervix during a pelvic exam. Squamous intraepithelial lesion is the pathology term that is used to refer to cervical dysplasia which is observed in smears of cells taken from the cervix. Cervical dysplasia is caused by infection with the human papillomavirus (HPV). HPV is a very common infection that is transmitted through sexual contact. Most new HPV infections occur in young (ages 15-25) women. Most HPV infections do not produce any symptoms and resolve spontaneously.

Market Dynamics:

Increasing organic strategies by the key market players is expected to drive the market growth over the forecast period. For instance, on March 1, 2021, INOVIO, a biotechnology company focused on bringing to market precisely designed deoxyribonucleic acid (DNA)medicines to treat and protect people from infectious diseases, cancer and HPV-associated diseases, announced that it met primary and secondary endpoints among all evaluable subjects for the REVEAL 1 trial. This trial is one of two ongoing pivotal, randomized, double-blind, multi-center, placebo-controlled, Phase 3 trials evaluating the safety, tolerability, and efficacy of VGX-3100 to treat HPV-16/18-associated cervical high-grade squamous intraepithelial lesions (HSIL) using the company's proprietary CELLECTRA 5PSP device.

Cervical Dysplasia Market Detailed Segmentation:

By Diagnosis Type
- Diagnosis Test
- HPV Test
- Pap Smear Test
- Biopsy Test
- Diagnostic Device
- Colposcope
By End User
- Hospitals
- Diagnostic Centers
- Ambulatory Surgery Centers
By Region
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East and Africa
Company Profiles
- Roche
- Qiagen
- Abbott Laboratories
- BD
- Hologic
- Seegene
- Arbor Vita
- Femasys
- Cooper Surgical

1. Research Objectives and Assumptions

Research Objectives
Assumptions
Abbreviations

2. Market Purview

Report Description
- Market Definition and Scope
Executive Summary
- Market Snippet, By Diagnosis Type
- Market Snippet, By End User
- Market Snippet, By Region
Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

Market Dynamics
- Drivers
Increasing government initiatives
Growing prevalence of cervical dysplasia globally
- Restraints
Lack of awareness in developing nations
- Opportunities
Increasing government funding
Key Highlights
Regulatory Scenario
Recent Trends
Product Launches/Approvals
PEST Analysis
PORTER's Analysis
Mergers, Acquisitions and Collaborations

4. Cervical Dysplasia Market- Impact of Coronavirus (COVID-19) Pandemic

COVID-19 Epidemiology
Supply Side and Demand Side Analysis
Economic Impact

5. Cervical Dysplasia Market, By Diagnosis Type, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025 and 2032 (%)
- Y-o-Y Growth Analysis, 2021 - 2032
- Segment Trends
Diagnosis Test
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
HPV Test
Pap Smear Test
Biopsy Test
Diagnostic Device
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Colposcope

6. Cervical Dysplasia Market, By End User, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, 2025and 2032 (%)
- Y-o-Y Growth Analysis, 2021- 2032
- Segment Trends
Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Diagnostic Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)
Ambulatory Surgery Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2020-2032,(US$ Mn)

7. Cervical Dysplasia Market, By Region, 2020-2032, (US$ Mn)

Introduction
- Market Share Analysis, By Region, 2025and 2032 (%)
- Y-o-Y Growth Analysis, For Region, 2021-2032
- Country Trends
North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.S.
  - Canada
Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - U.K.
  - Germany
  - France
  - Italy
  - Spain
  - Russia
  - Rest of Europe
Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - China
  - Japan
  - India
  - Australia
  - ASEAN
  - South Korea
  - Rest of Asia Pacific
Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - Brazil
  - Mexico
  - Argentina
  - Rest of Latin America
Middle East
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country, 2020-2032,(US$ Mn)
  - GCC Countries
  - Israel
  - Rest of Middle East
Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Diagnosis Type, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2020-2032,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2020-2032,(US$ Mn)
  - South Africa
  - North Africa
  - Central Africa

8. Competitive Landscape

Company Profile
- Roche
Company Highlights
Product Portfolio
Key Developments
Financial Performance
Strategies
- Qiagen
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- Abbott Laboratories
Company Highlights
Product Portfolio
Key Highlights
Financial Performance
Strategies
- BD
- Hologic
- Seegene
- Arbor Vita
- Femasys
- Cooper Surgical
- Analyst Views